These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15963657)

  • 1. Fascioscapulohumeral muscular dystrophy: a progressive degenerative disease that responds to diltiazem.
    Lefkowitz DL; Lefkowitz SS
    Med Hypotheses; 2005; 65(4):716-21. PubMed ID: 15963657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAGE-NF-kappaB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy.
    Macaione V; Aguennouz M; Rodolico C; Mazzeo A; Patti A; Cannistraci E; Colantone L; Di Giorgio RM; De Luca G; Vita G
    Acta Neurol Scand; 2007 Feb; 115(2):115-21. PubMed ID: 17212615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease.
    Sharer JD
    IUBMB Life; 2005 Sep; 57(9):607-14. PubMed ID: 16203679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot trial of diltiazem in facioscapulohumeral muscular dystrophy.
    Elsheikh BH; Bollman E; Peruggia M; King W; Galloway G; Kissel JT
    Neurology; 2007 Apr; 68(17):1428-9. PubMed ID: 17452589
    [No Abstract]   [Full Text] [Related]  

  • 6. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle.
    Laoudj-Chenivesse D; Carnac G; Bisbal C; Hugon G; Bouillot S; Desnuelle C; Vassetzky Y; Fernandez A
    J Mol Med (Berl); 2005 Mar; 83(3):216-24. PubMed ID: 15551024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of mu-crystallin in facioscapulohumeral muscular dystrophy.
    Reed PW; Corse AM; Porter NC; Flanigan KM; Bloch RJ
    Exp Neurol; 2007 Jun; 205(2):583-6. PubMed ID: 17451686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe phenotype in infantile facioscapulohumeral muscular dystrophy.
    Klinge L; Eagle M; Haggerty ID; Roberts CE; Straub V; Bushby KM
    Neuromuscul Disord; 2006 Oct; 16(9-10):553-8. PubMed ID: 16934468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic reticulum stress induces calcium-dependent permeability transition, mitochondrial outer membrane permeabilization and apoptosis.
    Deniaud A; Sharaf el dein O; Maillier E; Poncet D; Kroemer G; Lemaire C; Brenner C
    Oncogene; 2008 Jan; 27(3):285-99. PubMed ID: 17700538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of expression of muscle specific isoforms of the fragile X related protein 1 (FXR1P) in facioscapulohumeral muscular dystrophy patients.
    Davidovic L; Sacconi S; Bechara EG; Delplace S; Allegra M; Desnuelle C; Bardoni B
    J Med Genet; 2008 Oct; 45(10):679-85. PubMed ID: 18628314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANT1 overexpression models: Some similarities with facioscapulohumeral muscular dystrophy.
    Arbogast S; Kotzur H; Frank C; Compagnone N; Sutra T; Pillard F; Pietri S; Hmada N; Moussa DMA; Bride J; Françonnet S; Mercier J; Cristol JP; Dabauvalle MC; Laoudj-Chenivesse D
    Redox Biol; 2022 Oct; 56():102450. PubMed ID: 36030628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitization by knockdown of adenine nucleotide translocase-2.
    Le Bras M; Borgne-Sanchez A; Touat Z; El Dein OS; Deniaud A; Maillier E; Lecellier G; Rebouillat D; Lemaire C; Kroemer G; Jacotot E; Brenner C
    Cancer Res; 2006 Sep; 66(18):9143-52. PubMed ID: 16982757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy.
    Kan HE; Scheenen TW; Wohlgemuth M; Klomp DW; van Loosbroek-Wagenmans I; Padberg GW; Heerschap A
    Neuromuscul Disord; 2009 May; 19(5):357-62. PubMed ID: 19329315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of Ca2+ handling drugs against abnormal Ca2+ homeostasis and cell damage in myopathic skeletal muscle cells.
    Iwata Y; Katanosaka Y; Shijun Z; Kobayashi Y; Hanada H; Shigekawa M; Wakabayashi S
    Biochem Pharmacol; 2005 Sep; 70(5):740-51. PubMed ID: 16009351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models.
    Iwata Y; Katanosaka Y; Arai Y; Shigekawa M; Wakabayashi S
    Hum Mol Genet; 2009 Mar; 18(5):824-34. PubMed ID: 19050039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-dependent alteration of the ADP/ATP translocator triggers the mitochondrial permeability transition which is not required for the low-potassium-dependent apoptosis of cerebellar granule cells.
    Atlante A; Bobba A; de Bari L; Fontana F; Calissano P; Marra E; Passarella S
    J Neurochem; 2006 May; 97(4):1166-81. PubMed ID: 16606362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of peroxidized cardiolipin with rat-heart mitochondrial membranes: induction of permeability transition and cytochrome c release.
    Petrosillo G; Casanova G; Matera M; Ruggiero FM; Paradies G
    FEBS Lett; 2006 Nov; 580(27):6311-6. PubMed ID: 17083938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Becker's muscular dystrophy aggravating facioscapulohumeral muscular dystrophy--double trouble as an explanation for an atypical phenotype.
    Rudnik-Schöneborn S; Weis J; Kress W; Häusler M; Zerres K
    Neuromuscul Disord; 2008 Nov; 18(11):881-5. PubMed ID: 18684626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the mitochondrial membrane permeability transition in cell death.
    Tsujimoto Y; Shimizu S
    Apoptosis; 2007 May; 12(5):835-40. PubMed ID: 17136322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha.
    Gao Q; Zhang SZ; Cao CM; Bruce IC; Xia Q
    Cytokine; 2005 Dec; 32(5):199-205. PubMed ID: 16260145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.